Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Valeo Pharma's change in inventory for the quarter that ended in Jul. 2024 was $1.08 Mil. It means Valeo Pharma's inventory
declined by $1.08 Mil
from Apr. 2024 to Jul. 2024 .
Valeo Pharma's change in inventory for the fiscal year that ended in Oct. 2023 was $-1.29 Mil. It means Valeo Pharma's inventory
increased by $1.29 Mil
from Oct. 2022 to Oct. 2023 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Valeo Pharma's Days Inventory for the quarter that ended in Jul. 2024 was 55.14.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Valeo Pharma's Inventory Turnover for the quarter that ended in Jul. 2024 was 1.65.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Valeo Pharma's Inventory-to-Revenue for the quarter that ended in Jul. 2024 was 0.46.
Valeo Pharma (OTCPK:VPHIF) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Valeo Pharma's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Valeo Pharma's Inventory to Revenue for the quarter that ended in Jul. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valeo Pharma Change In Inventory Related Terms
Valeo Pharma Change In Inventory Historical Data
* Premium members only.
The historical data trend for Valeo Pharma's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of $3.93 Mil mean?
Valeo Pharma (VPHIF) has a Change In Inventory of $3.93 Mil as of Jul. 2024. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Valeo Pharma and its competitors.
Is Valeo Pharma's Change In Inventory too high?
Valeo Pharma's current Change In Inventory is $3.93 Mil. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Change In Inventory compare to ZTS?
Valeo Pharma's Change In Inventory of $3.93 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Valeo Pharma and its competitors. Valeo Pharma's current Change In Inventory is $3.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Change In Inventory of $3.93 Mil. The current Change In Inventory is $3.93 Mil. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Change In Inventory is $3.93 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score
Get the complete analysis for VPHIF
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VPHIF has been successfully added to your 
